• Facebook
  • X
  • Instagram
MYELOMA360
  • Home
  • Myinsights
  • MYBoard
  • Strategy & Consulting
Select Page

Evolving Myelofibrosis Treatments Aims to Fill Unmet Needs

by MM360 Staff | May 21, 2025 | Uncategorized

Source: CureToday articles JAK inhibitors ease symptoms in myelofibrosis, but only stem cell transplant offers a cure; newer drugs aim to fill unmet needs, especially for anemia. Read More

Understanding the Evolution of Waldenström Macroglobulinemia Treatment

by MM360 Staff | May 21, 2025 | Uncategorized

Source: CureToday articles Dr. Shirley D’Sa discusses how treatment strategies for WM have evolved over the course of her career. Read More

When Others say Your Own Thoughts About Cancer Aloud

by MM360 Staff | May 21, 2025 | Uncategorized

Source: CureToday articles I’m a follicular lymphoma survivor, and hearing others name the quiet, lasting changes of life after cancer made me feel seen and understood. Read More

FDA Grants Fast Track Designation to ZL-1310 in Small Cell Lung Cancer

by MM360 Staff | May 21, 2025 | Uncategorized

Source: CureToday articles ZL-1310 earns fast track designation in extensive-stage small cell lung cancer after early trial data showed tumor shrinkage in most patients treated. Read More

FDA’s ODAC Casts Votes on the Use of Certain Treatment Options in Cancer Care

by MM360 Staff | May 21, 2025 | Uncategorized

Source: CureToday articles The FDA’S ODAC has casted their votes on the use of certain treatments in both the relapsed/refractory DLBCL and myeloma patient populations, respectively. Read More

Sixteen Years With Leukemia Taught Me to Savor Life

by MM360 Staff | May 21, 2025 | Uncategorized

Source: CureToday articles I’ve lived with large granular lymphocytic leukemia for 16 years and have learned to spend my energy wisely, embrace palliative care and choose joy over anger. Read More
« Older Entries
Next Entries »

Recent Content

  • Ambulatory Pharmacy in Action: House Calls and Harm Reduction Clinics Expand the Reach of Care
  • Detailing the Potential Benefit of Intratumoral Therapies in Lung Cancer
  • Reimagining Pain Management: Pharmacists Urged to “Deconstruct the Cupcake”
  • Specialty Pharmacist Integration in Neurology Clinics: A Model for Enhanced Patient Care
  • Targeted Chemo Improves Survival in Early-Stage Lung Cancer
  • Utilizing AI in Prostate Cancer Care and Management
  • KITE-363 Shows High Response in B-Cell Lymphoma With Manageable Safety
  • Rilonacept in Recurrent Pericarditis: Mechanism of Action, Patient Management, and Clinical Considerations
  • Zyprexa Added to Standard Antiemetics Reduces Nausea, Vomiting in Radiation
  • Op-Ed: Expand Patient Choice to Lower Medication Costs
  • Facebook
  • X
  • Instagram
©2016-2025 MYELOMA360 & Connect BioMed
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
Do not sell my personal information.
SettingsAccept
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
SAVE & ACCEPT